Grey Matters Health Inc. (CSE:GREY)
Canada · Delayed Price · Currency is CAD 0.4300
+0.0300 (7.50%)
Jul 14, 2026, 3:16 PM EST
Grey Matters Health Company Description
Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia.
The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program.
Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries.
The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026.
Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Grey Matters Health Inc.
| Country | Canada |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Christopher Moreau |
Contact Details
Address: 601 West Broadway Vancouver, BC V5Z 4C2 Canada | |
| Phone | 604 398 4175 |
| Website | greymatters-health.com |
Stock Details
| Ticker Symbol | GREY |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | September - August |
| Reporting Currency | CAD |
| ISIN Number | CA3978841078 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Christopher J. Moreau | Chief Executive Officer and Director |
| Dr. Christopher Bryan Ph.D. | Vice President of Research and Operations |
| Paul Moreau | Chief Marketing and Communications Officer |